Lepu Medical clinical trials

The registry lists 36 studies whose lead sponsor is Lepu Medical or one of 1 company grouped under it. 14 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 17, 2026.

Studies

Recruiting first, then most recently updated. Showing 36 of 36.

• Phase 1 Clinical Study of MWN117 Injection in Healthy Participants and Participants With ObesityNot yet recruitingNCT07824804Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes MellitusRecruitingNCT07801820Phase 2

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 2 Clinical Study of MWX203 Injection Alone or in Combination With Inclisiran Sodium Injection in Patients With Mixed DyslipidemiaRecruitingNCT07803822Phase 2

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or ObesityRecruitingNCT07803809Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 1 Clinical Study of MWX401 Injection in Chinese Healthy Participants and Participants With Mild HypertensionRecruitingNCT07803835Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 1 Clinical Study of MWN110 Injection in Healthy Participants and Overweight or Obese ParticipantsNot yet recruitingNCT07779980Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 3 Study of MWN109 Injection in Participants With Overweight or ObesityNot yet recruitingNCT07778693Phase 3

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MWX205Not yet recruitingNCT07634510Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• A Study to Evaluate MWN109 Tablets in Healthy Adult ParticipantsRecruitingNCT06938269Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary HypertensionRecruitingNCT07051811Not applicable

  Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.

• A Study to Evaluate MWN109 Injection in Healthy SubjectsRecruitingNCT06859853Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Study on the Efficacy and Safety of Rechargeable Implantable DBS System in the Treatment of Parkinson's DiseaseRecruitingNCT05997667Not applicable

  Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.

• Safety and Efficacy of SinocrownTM Transcatheter Aortic Valve Replacement SystemEnrolling by invitationNCT05202977Not applicable

  Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.

• Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS SystemNot yet recruitingNCT04995159Not applicable

  Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.

• Phase 2 Clinical Study of MWN105 Injection in Participants With Overweight or ObesityCompletedNCT07804810Phase 2

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 2 Study of MWN109 Tablet for Weight-Loss Maintenance in Participants With Overweight or ObesityActive, not recruitingNCT07804797Phase 2

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 1 Clinical Study of MWN105 Injection in Healthy Chinese VolunteersCompletedNCT07801313Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• A Study to Evaluate Different Administration Conditions and the Food Effect of MWN109 Tablets in Chinese ParticipantsCompletedNCT07801326Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 1 Clinical Study of MWX203 Injection in Healthy SubjectsActive, not recruitingNCT07799025Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase Ib Clinical Study of MWN109 Injection in Participants With Overweight or ObesityCompletedNCT07787728Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 2 Study of MWN109 Tablet in Participants With Overweight or ObesityCompletedNCT07791524Phase 2

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight or ObesityCompletedNCT07791654Phase 2

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With OverweightActive, not recruitingNCT07791537Phase 2

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase I Clinical Study of MWN109 Tablets in Healthy Chinese ParticipantsCompletedNCT07787611Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 1 Clinical Study of MWN109 Injection in Healthy Chinese VolunteersCompletedNCT07787624Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• To Evaluate the Efficacy and Safety of Multi-parameter Non-Invasive Glucose Sensors for for Blood Glucose MeasurementCompletedNCT06017349Not applicable

  Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.

• Treatment of Urethral Stricture With Urethral Drug BallStatus unknownNCT05812482Not applicable

  Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.

• Ultrasound Ablation for Essential Hypertension（FIM）Status unknownNCT05795829Not applicable

  Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.

• Clinical Trials of Pulsed Sonic Balloon Dilatation Catheter and Pulsed Sonic GeneraterStatus unknownNCT05406869Not applicable

  Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.

• Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary LesionsStatus unknownNCT05101005Not applicable

  Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.

• A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel DiseaseStatus unknownNCT04953117Not applicable

  Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.

• NeoVas Bioresorbable Coronary Scaffold Registry StudyStatus unknownNCT02305472Not applicable

  Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.

• NeoVas Bioresorbable Coronary Scaffold Randomized Controlled TrialStatus unknownNCT02305485Not applicable

  Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.

• NeoVas Bioresorbable Coronary Scaffold First-in-Man StudyStatus unknownNCT02195414Phase 1

  Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.

• Efficacy and Safety of Nano+ Polymer-free Sirolimus-Eluting Stent: A Optical Coherent Tomography StudyStatus unknownNCT01925027Phase 4

  Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.

• LEPU Renal Denervation System for Resistant HypertensionCompletedNCT02536326Phase 3

  Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.